| P50 | author | Lisa Pasterk | Q114330626 |
| | Markus Trieb | Q114402133 |
| | Sandra Lemesch | Q114402134 |
| | Sanja Curcic | Q114402142 |
| | Bettina Leber | Q63991534 |
| | Vanessa Stadlbauer-köllner | Q42631472 |
| | Gunther Marsche | Q43163492 |
| | Akos Heinemann | Q43163496 |
| P2093 | author name string | Rudolf Schicho | |
| | Rufina Schuligoi | |
| P2860 | cites work | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| | Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia | Q27027864 |
| | Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets | Q70284698 |
| | Plasma parameters of the prothrombotic state in chronic uremia | Q70592809 |
| | Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 |
| | Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure | Q77186319 |
| | Chronic renal failure--a vasculopathic state | Q77300296 |
| | Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model | Q79485403 |
| | Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality | Q80400868 |
| | Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury | Q84970924 |
| | Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. | Q44528051 |
| | Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia | Q45013438 |
| | What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach | Q46071833 |
| | Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase | Q46237674 |
| | Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation | Q46960624 |
| | The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions. | Q53400402 |
| | Characterization of oxidation end product of plasma albumin 'in vivo'. | Q54372473 |
| | Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin | Q57980347 |
| | Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 |
| | Platelet activation on hemodialysis: influence of dialysis membranes | Q61914851 |
| | Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment | Q67689047 |
| | Haemodialysis and platelet activation | Q67696475 |
| | Redox control of platelet functions in physiology and pathophysiology | Q33413673 |
| | Platelet hyperreactivity, scavenger receptors and atherothrombosis | Q33801221 |
| | Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite | Q34048534 |
| | Importance of oxidatively modified proteins in chronic renal failure | Q34135858 |
| | The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors | Q34178582 |
| | Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation | Q34368772 |
| | Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. | Q34592643 |
| | Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. | Q34600458 |
| | Aging affects high-density lipoprotein composition and function | Q34781392 |
| | Signaling during platelet adhesion and activation | Q34895427 |
| | Cardiovascular complications in chronic kidney disease | Q35140917 |
| | Cyanate is a novel inducer of endothelial icam-1 expression | Q35567375 |
| | The endothelium and platelets in cardiovascular disease: potential targets for therapeutic intervention | Q35867384 |
| | Oxidative stress in uremia: nature, mechanisms, and potential consequences | Q35921174 |
| | Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo | Q36032978 |
| | Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit | Q36250944 |
| | Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway | Q36415711 |
| | Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL. | Q36681188 |
| | Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway | Q36893819 |
| | Platelet procoagulant activity: physiological significance and mechanisms of exposure | Q36928487 |
| | Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 |
| | HDL scavenger receptor class B type I and platelet function | Q37871283 |
| | Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities | Q37998174 |
| | Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. | Q38493208 |
| | The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis | Q39343357 |
| | Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds | Q40681776 |
| | The urea decomposition product cyanate promotes endothelial dysfunction | Q42025075 |
| | The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation | Q42821512 |
| | Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease | Q43545029 |
| | Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway | Q44141875 |
| | Deceased-donor characteristics and the survival benefit of kidney transplantation | Q44291877 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 22104 | |
| P577 | publication date | 2016-02-24 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression | |
| P478 | volume | 6 | |